ds to totally take over from a WM Capital Markets perspective as I already discussed with Dan several times, at least for OTC Derivs, but then some non-KCP eligible clients (WM Americas has 316 OTC clients into GM systems) might get caught in the system. It's all very technical, but we need to urgently